Investing.com -- S&P Global Ratings recently upgraded the credit rating of Alfa S.A.B. de C.V. from ’BBB-’ to ’BBB’. The upgrade, announced on April 7, 2025, comes after Alfa completed the ...

Investing.com -- S&P Global Ratings recently upgraded the credit rating of Alfa S.A.B. de C.V. from ’BBB-’ to ’BBB’. The upgrade, announced on April 7, 2025, comes after Alfa completed the spin-off of ...

Watching from a flight to Latin America, NYU professor and valuation expert Aswath Damodaran saw not just panic, but the anatomy of a full-blown market crisis in motion. In his latest blog ...

Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple ...

We picked Discover Money Market Account because you earn a competitive yield, endure few fees and have check-writing privileges, among other benefits. Discover scores well on customer service ...

CNBC Select will update as changes are made public. Money market accounts are another type of savings account where you can stash your cash to earn interest and grow over time. Money market ...

Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple ...

Here's why he sees more pain ahead — and where investors can hide. Goldman Sachs expects a 30% decline in the stock market, which would send the S&P 500 to about 4,300, or 18% lower from current ...

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 10, 2025. REUTERS/Jeenah Moon/File Photo Investors pulled out of U.S. bond funds heavily in the week ...

[BRIEFING.COM] The stock market exhibited extreme turbulence on the first session of the week on above-average volume. The S&P 500 (-0.2%), which traded in bear market territory (i.e., 20% below its ...

Denali Therapeutics Inc. (NASDAQ: DNLI) has announced the initiation of a rolling submission of a Biologics License Application (BLA) for accelerated approval of Tividenofusp alfa for the treatment ..